MedPath

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

Phase 2
Completed
Conditions
Schizophrenia
Tobacco Use Disorder
Interventions
Behavioral: smoking abstinence
Registration Number
NCT01214005
Lead Sponsor
Brown University
Brief Summary

This project tests two hypotheses concerning the low smoking cessation rates in smokers with schizophrenia. The first hypothesis is that smokers with schizophrenia experience stronger and more sustained effects of smoking abstinence on negative mood and smoking urge than control smokers without psychiatric illness. The second hypothesis is that smokers with schizophrenia experience stronger reinforcing effects of a smoking lapse (i.e., more rewarding effects of smoking after a period of abstinence) than control smokers without psychiatric illness.

Detailed Description

In this study, smokers with schizophrenia and smokers without psychiatric illness participate in a nicotine preference task before and after a 3-day period of continuous smoking abstinence. The investigators will experimentally control abstinence by providing participants with high-value cash incentives contingent upon smoking abstinence verified with breath carbon monoxide levels. The investigators will measure nicotine withdrawal and smoking urge during the abstinence period. In the nicotine preference task, participants will make choices between nicotine-containing and denicotinized cigarette puffs to provide a measure of nicotine reinforcement, and the investigators will also measure the effects of smoking on mood. After the second nicotine preference task, participants will receive a small-value reinforcer if they continue to abstain for another day, and the investigators will measure time to the second lapse.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • cigarette smokers, 20-50 cigarettes per day
  • schizophrenia or no psychiatric illness
  • age 18 or older
  • male or female
Exclusion Criteria
  • unstable symptoms or medication
  • not interested in quitting smoking within 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
schizophreniasmoking abstinenceSmokers with schizophrenia or schizoaffective disorder
non-psychiatricsmoking abstinencesmokers without psychiatric illness
Primary Outcome Measures
NameTimeMethod
Withdrawal symptoms3 days

negative mood related to nicotine withdrawal

urge to smoke3 days

craving for smoking

positive and negative moodbefore and after 3 days of abstinence

positive and negative mood scale

nicotine preferencebefore and after 3 days of abstinence

choice for nicotine puffs versus denicotinized cigarette puffs

Secondary Outcome Measures
NameTimeMethod
time to lapse192 hours

time between smoking behavior in the laboratory and first cigarette outside of the laboratory

Trial Locations

Locations (1)

Brown University, 121 South Main Street

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath